Tacrolimus (FK506)-Associated Renal Pathology.
作者信息
Randhawa Parmjeet S, Starzl Thomas E, Demetris Anthony Jake
机构信息
Division of Transplantation Pathology, Department of Pathology and University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, U.S.A.
出版信息
Adv Anat Pathol. 1997 Jul;4(4):265-276. doi: 10.1097/00125480-199707000-00032.
Abstract
摘要
相似文献
1
Tacrolimus (FK506)-Associated Renal Pathology.他克莫司（FK506）相关的肾脏病理学。
Adv Anat Pathol. 1997 Jul;4(4):265-276. doi: 10.1097/00125480-199707000-00032.
2
[Correlation of blood concentration of tacrolimus with serum cystatin C in renal transplant recipients and effect of tacrolimus on glucose and lipid metabolism].肾移植受者他克莫司血药浓度与血清胱抑素C的相关性及他克莫司对糖脂代谢的影响
Nan Fang Yi Ke Da Xue Xue Bao. 2017 Jun 20;37(6):817-820. doi: 10.3969/j.issn.1673-4254.2017.06.18.
3
FXR activation alleviates tacrolimus-induced post-transplant diabetes mellitus by regulating renal gluconeogenesis and glucose uptake.FXR 激活通过调节肾脏糖异生和葡萄糖摄取来减轻他克莫司诱导的移植后糖尿病。
J Transl Med. 2019 Dec 13;17(1):418. doi: 10.1186/s12967-019-02170-5.
4
[Clinical study of tacrolimus in postoperative treatment of patients with renal transplantation for diabetic end-stage renal disease].他克莫司用于糖尿病终末期肾病肾移植患者术后治疗的临床研究
Di Yi Jun Yi Da Xue Xue Bao. 2003 Nov;23(11):1146-8.
5
Clinical and histopathologic examination of renal allografts treated with tacrolimus (FK506) for at least one year.对接受他克莫司（FK506）治疗至少一年的同种异体肾移植进行临床和组织病理学检查。
Int J Urol. 1998 Nov;5(6):526-33. doi: 10.1111/j.1442-2042.1998.tb00406.x.
6
Skin allograft survival and analysis of renal parameters after FTY720 + tacrolimus treatment in mice.FTY720联合他克莫司治疗小鼠后皮肤同种异体移植存活情况及肾脏参数分析
Transplant Proc. 2008 Apr;40(3):856-60. doi: 10.1016/j.transproceed.2008.02.051.
7
The calcineurin inhibitor FK506 (tacrolimus) is associated with transient metabolic acidosis and altered expression of renal acid-base transport proteins.钙调神经磷酸酶抑制剂FK506（他克莫司）与短暂性代谢性酸中毒及肾酸碱转运蛋白表达改变有关。
Am J Physiol Renal Physiol. 2009 Aug;297(2):F499-509. doi: 10.1152/ajprenal.90489.2008. Epub 2009 May 13.
8
Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.FK506（他克莫司）在小儿肾移植受者中的初步经验。
J Pediatr Surg. 1997 May;32(5):688-90. doi: 10.1016/s0022-3468(97)90006-3.
9
Tacrolimus in combination with FTY720--an analysis of renal and blood parameters.他克莫司与FTY720联合使用——肾脏和血液参数分析
Int Immunopharmacol. 2006 Dec 20;6(13-14):1919-24.
10
Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy.与FK506（他克莫司）治疗相关的肾移植微血管变化。
Am J Surg Pathol. 1996 Mar;20(3):306-12. doi: 10.1097/00000478-199603000-00007.
引用本文的文献
1
Kidney transplantation between identical twins with APOL1 homozygote risk alleles - a case report.具有APOL1纯合子风险等位基因的同卵双胞胎间肾移植——病例报告
Front Nephrol. 2025 Jul 31;5:1648263. doi: 10.3389/fneph.2025.1648263. eCollection 2025.
2
Influence of pre-transplant estimated glomerular filtration rate (eGFR) on clinical outcomes after allogeneic hematopoietic cell transplantation.移植前估计肾小球滤过率（eGFR）对异基因造血细胞移植后临床结局的影响。
Bone Marrow Transplant. 2025 Apr 2. doi: 10.1038/s41409-025-02556-8.
3
Tacrolimus- and Mycophenolate-Mediated Toxicity: Clinical Considerations and Options in Management of Post-Transplant Patients.他克莫司和霉酚酸介导的毒性：移植后患者管理中的临床考量与选择
Curr Issues Mol Biol. 2024 Dec 24;47(1):2. doi: 10.3390/cimb47010002.
4
Thirty years of lung transplantation: development of postoperative outcome and survival over three decades.肺移植三十年：三十年间术后结局与生存情况的发展
J Thorac Dis. 2024 Dec 31;16(12):8513-8527. doi: 10.21037/jtd-24-326. Epub 2024 Dec 28.
5
A genotype-guided prediction model for the incidence of persistent acute kidney injury following lung transplantation.肺移植后持续性急性肾损伤发生率的基因型导向预测模型。
BMC Nephrol. 2024 Dec 18;25(1):458. doi: 10.1186/s12882-024-03871-w.
6
Bacteria Endocarditis Caused by in a Juvenile, Immunosuppressed Pig () following Partial Heart Transplantation.在一只接受过部分心脏移植的幼年免疫抑制猪（）中，由 引起的细菌心内膜炎。
Comp Med. 2024 Aug 1;74(4):295-303. doi: 10.30802/AALAS-CM-23-000090. Epub 2024 May 15.
7
Unveiling APOL1 haplotypes in a predominantly African-American cohort of kidney transplant patients: a novel classification using probe-independent quantitative real-time PCR.在以非裔美国人为主的肾移植患者队列中揭示APOL1单倍型：一种使用无需探针的定量实时PCR的新型分类方法。
Front Med (Lausanne). 2024 Apr 10;11:1325128. doi: 10.3389/fmed.2024.1325128. eCollection 2024.
8
Age-Related Brain Atrophy and the Positive Effects of Behavioral Enrichment in Middle-Aged Beagles.中老年比格犬的年龄相关性脑萎缩与行为丰富化的积极影响。
J Neurosci. 2024 May 15;44(20):e2366232024. doi: 10.1523/JNEUROSCI.2366-23.2024.
9
Falsely Elevated Tacrolimus (FK506) Trough Levels in a Liver Transplant Recipient.肝移植受者中环孢素A（FK506）谷浓度假性升高
Cureus. 2024 Feb 20;16(2):e54548. doi: 10.7759/cureus.54548. eCollection 2024 Feb.
10
The prevalence of vascular and metabolic complications after lung transplant in people with cystic fibrosis in a Dutch cohort.荷兰队列研究中肺移植后囊性纤维化患者血管和代谢并发症的流行情况。
Clinics (Sao Paulo). 2023 Aug 17;78:100274. doi: 10.1016/j.clinsp.2023.100274. eCollection 2023.
本文引用的文献
1
Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients.肾移植受者急性可逆性他克莫司（FK 506）肾毒性的临床特征
Clin Transplant. 1997 Jun;11(3):237-42.
2
Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation.肝肾功能移植后FK506全血浓度与疗效及毒性的关系。
Transplantation. 1996 Oct 15;62(7):920-6. doi: 10.1097/00007890-199610150-00009.
3
Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies.他克莫司治疗难治性急性肾移植排斥反应：通过方案活检确定组织学反应的定义
Transplantation. 1996 Oct 15;62(7):906-10. doi: 10.1097/00007890-199610150-00006.
4
An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group.FK506用于原发性肾移植的开放标签、浓度范围试验：美国多中心FK506肾移植组报告
Transplantation. 1996 Oct 15;62(7):900-5. doi: 10.1097/00007890-199610150-00005.
5
Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation.肾及肾胰联合移植后环孢素相关血栓性微血管病/溶血尿毒综合征
Am J Kidney Dis. 1996 Oct;28(4):561-71. doi: 10.1016/s0272-6386(96)90468-0.
6
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.FK506（他克莫司）治疗难治性急性肾移植排斥反应的多中心试验。他克莫司肾移植挽救研究组报告。
Transplantation. 1996 Sep 15;62(5):594-9. doi: 10.1097/00007890-199609150-00009.
7
The coagulo-lytic system and endothelial function in cyclosporine-treated kidney allograft recipients.环孢素治疗的肾移植受者的凝血溶解系统和内皮功能。
Transplantation. 1996 Sep 27;62(6):828-30. doi: 10.1097/00007890-199609270-00021.
8
Quinacrine attenuates cyclosporine-induced nephrotoxicity in rats.喹吖因减轻环孢素诱导的大鼠肾毒性。
Transplantation. 1996 Aug 27;62(4):427-35. doi: 10.1097/00007890-199608270-00001.
9
Progressive histologic injury in kidneys from heart and liver transplant recipients receiving cyclosporine.接受环孢素治疗的心脏和肝脏移植受者肾脏中进行性组织学损伤。
Transplantation. 1996 Aug 15;62(3):364-70. doi: 10.1097/00007890-199608150-00011.
10
Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model.环孢素与雷帕霉素在慢性肾毒性模型中的协同作用。
Transplantation. 1996 Aug 15;62(3):311-6. doi: 10.1097/00007890-199608150-00002.
Zotero 插件